Efficacy and Safety of the Platelet-Activating Factor Receptor Antagonist BN???52021 (Ginkgolide??B) in Patients with Severe Sepsis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of the Platelet-Activating Factor Receptor Antagonist BN???52021 (Ginkgolide??B) in Patients with Severe Sepsis

Published:2004 Issue:3 Volume:24 Page:137-147
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Albrecht D M,van Ackern K,Bender H -J,Hof H,Kox W,Victor N,Funk P,Kieser M,K??hler S,Krausch D,Marzi I,Menges T,Schmidt H

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference29 articles.

1. Synthesis of PAF-acether and blood volume changes in gram-negative sepsis

2. Intravascular release of platelet activating factor in children with sepsis

3. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.

4. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginkgolide A attenuates sepsis-associated kidney damage via upregulating microRNA-25 with NADPH oxidase 4 as the target;International Immunopharmacology;2021-06

2. Neuroprotective effects of Ginkgolide B in focal cerebral ischemia through selective activation of prostaglandin E2 receptor EP4 and the downstream transactivation of epidermal growth factor receptor;Phytotherapy Research;2021-01-15

3. Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling;Prostaglandins & Other Lipid Mediators;2020-12

4. Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic Review;Critical Care Medicine;2019-12

5. Non-cultured dermal-derived mesenchymal cells attenuate sepsis induced by cecal ligation and puncture in mice;Scientific Reports;2015-11-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3